Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three different drug classes that is sometimes used together for sedation, particularly during endoscopic procedures. The combination includes propofol (an anesthetic agent), benzodiazepines (sedatives), and opioids (pain medications). According to the search results, this combination is used in clinical practice for sedation during procedures, though there are important safety considerations. The search results indicate that propofol used alone or in combination with benzodiazepines and/or opioids appears to be safe for endoscopic procedures when properly administered[3]. There was a trend toward increased incidence of bradycardia in patients receiving propofol with benzodiazepine and opioid sedation compared to those on propofol alone, though this difference was not statistically significant[3]. The combination is used to obtain adequate depth of sedation while potentially avoiding high dose-related side effects of propofol alone[3]. It's important to note that combining opioids with benzodiazepines generally carries significant risks, as both drug classes can cause sedation and respiratory depression[1][2]. This combination requires careful monitoring and appropriate medical supervision. The specific drugs that might be used in this combination could include: - Propofol (anesthetic) - Benzodiazepines such as diazepam (Valium), alprazolam (Xanax), clonazepam (Klonopin), or midazolam - Opioids such as fentanyl, morphine, or hydrocodone This combination would typically be administered in controlled medical settings such as hospitals or endoscopy centers under the supervision of anesthesiologists or other qualified healthcare providers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Propofol, Benzodiazepine, and Opioid Combination.